Dartmouth Medical School and the Maine Army National Guard have joined to launch a two-tiered Mild Traumatic Brain Injury (mTBI) Program involving both state-of-the-art screening and a system of integrated care to meet the needs of returning soldiers through cooperation between private and public community-based providers.
Dartmouth pediatrician Dr. John Modlin, a prominent children's infectious disease expert, has been appointed senior associate dean for clinical affairs at Dartmouth Medical School, effective immediately. In this position, he will serve in an advisory role to DMS Dean Dr. William R. Green for all aspects relating to the school's academic mission involving the clinical faculty and programs at Dartmouth-Hitchcock Medical Center.
Dr. Ethan Dmitrovsky, the Andrew Wallace Professor of Pharmacology and Toxicology and professor of medicine at Dartmouth Medical School, has been named a Clinical Research Professor by the American Cancer Society.
Increasing the size of the physician workforce has not led overall to better care, greater availability of care or patient satisfaction with medical care. So why do some continue to argue that adding more doctors is critical to addressing the US health care crisis? That's the question posed by Dartmouth Medical School physicians David C. Goodman and Elliott S. Fisher in the April 17 New England Journal of Medicine.
Dartmouth Medical School geneticists have pinpointed the terminator controls in a pathway for cells destined to live or die, switching on a killer gene when needed to assure the development of a healthy animal.
Medicare pays many hospitals and their doctors more than the most efficient and effective health care institutions to treat chronically ill people, yet gets worse results, according to a new report from the Dartmouth Institute for Health Policy and Clinical Practice by Dartmouth Medical School professors.
Joining their counterparts across the country, graduating Dartmouth Medical School students celebrated Match Day, a rite of passage when they learn where they will begin their training as newly minted physicians.
Using a promising model they devised to study the stubborn lung infections that plague cystic fibrosis (CF) patients, Dartmouth Medical School researchers have discovered strikingly strong resistance to conventional antibiotics, and suggest that the intense therapy needed to combat infection may contribute to its persistence.